"There has to be an inter-sectoral approach for proper implementation of strategies and programmes to eliminate malaria from the country.
"Also, there is a need to carry out research on traditional methods of medicines, mostly used in rural India," he said while announcing India's first public-private partnership agreement for research and innovation in preventive health between ICMR and Sun Pharma.
Nadda said this initiative was a significant step in the health sector and reaffirmed the commitment of the government to strengthen health research.
As part of the partnership, ICMR and Sun Pharma will establish a malaria elimination demonstration project -- 'Malaria Free India' -- to support the National Framework for Elimination of Malaria which was announced by the Health Ministry in February 2016.
Nadda said this collaboration will prove to be a "notable milestone" in the government's strategy to eliminate malaria.
"India is a party to the commitment at the East Asia Summit for malaria elimination by 2030. So today's announcement of malaria elimination demonstration project is of special significance," he said.
"Through our Malaria Free India initiative, we aim to achieve zero malaria incidences in more than 1,200 villages of Mandla district of Madhya Pradesh by FY'21," Shanghvi said.
"The experience gained from Mandla project will guide the development of broader plans for malaria elimination in Madhya Pradesh and other high malaria endemic states," he said.
Sun Pharma will fund as well as execute the programme over three to five years covering over 2,00,000 households in Mandla district, in collaboration with Madhya Pradesh government.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
